2021
DOI: 10.21873/cgp.20282
|View full text |Cite
|
Sign up to set email alerts
|

Cisplatin and Pemetrexed Have Distinctive Growth-inhibitory Effects in Monotherapy and Combination Therapy onKRAS-dependent A549 Lung Cancer Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 86 publications
(95 reference statements)
0
2
0
Order By: Relevance
“…In addition, advanced lung cancer has a lower life quality than caregivers of patients with other chronic diseases. Therefore, in the process of cancer management, the view of “focusing on the patient's disease participation while ignoring the patient's psychological and social function” is out of date [ 24 ]. More scholars encourage to regard cancer as a stressful event involving patients.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, advanced lung cancer has a lower life quality than caregivers of patients with other chronic diseases. Therefore, in the process of cancer management, the view of “focusing on the patient's disease participation while ignoring the patient's psychological and social function” is out of date [ 24 ]. More scholars encourage to regard cancer as a stressful event involving patients.…”
Section: Discussionmentioning
confidence: 99%
“…It suggests that cisplatin may trigger apoptotic cell injury in the rat hearts to induce cardiac injury. Cisplatin is an antineoplastic drug and widely used in the treatment of different types of tumors 25 , 26 . However, chemotherapy with cisplatin leads to various side effects including increase in cardiac injury 27 , 28 .…”
Section: Discussionmentioning
confidence: 99%